news about mushrooms
Learn what people are saying about psilocybin from news outlets around the globe.
Huffpost: Psychedelic Microdosing Research
A leading psychedelic researcher explains everything you want to know about microdosing.
Medium: How 1 Year of Microdosing Helped My Career, Relationships & Happiness
A year-long experience using psilocybin — also known as ‘shrooms’ or ‘magic mushrooms’ — almost daily.
The Cut: New Research on psilocybin
Psilocybin, the Active Ingredient in ’Shrooms, Is Looking More and More Like a Potential Wonder Drug
The Third Wave: Psilocybin & Treatment
Recently, psychiatrists and therapists have turned to the classic psychedelic psilocybin to aid end-of-life anxiety.
CBC: New Study on Microdosing
How and why people ‘microdose’ tiny hits of psychedelic drugs
The Cut: A Guide to Microdosing
Consuming crumb-size amounts of psychedelics — not to get high but to feel more focused and creative and present.
The Guardian: How Magic Mushrooms Can Aid Depression
Immediate reduction in depression and anxiety for up to eight months seen in patients with advanced cancer given a single dose of psilocybin.
Scientific American: Scientists Test Claims about Microdosing
Scientists examine if psychedelics could lead to improved antidepressant or anti-anxiety therapies.
Vice: Microdosing Improves Quality of Life
Vice interviews the researcher behind one of the first ever studies on microdosing.
CBC: Researchers Study How & Why people Use Magic Mushrooms
Study finds overwhelming positive and sometimes transformative experiences with magic mushrooms.
The Globe & Mail: The Renaissance in Psychedelic Science
Researchers have study psilocybin magic mushrooms potential for treating depression, PTSD, and mood disorders.
Stat News: Science is Testing the Claims of Microdosing Magic Mushrooms
‘Microdosing’ is touted by ’shroomers and Reddit users. Science is starting to test their claims — and finding some truth.
Huffpost: Can Psychedelic Drugs Treat Mental Illness?
A new crowdfunding campaign seeks to raise $2 million to advance promising research.
Vancouver’s Research on Psychedelics
The B.C. Centre on Substance Use has assembled a team that’s positioning Vancouver as a global force in investigating psilocybin magic mushrooms for the treatment of addiction and mental disorders.
Psycology Today: Psilocybin Magic Mushrooms are a Radical New Approach to Beating Addiction
Psychedelic drugs are in the vanguard of treatment for addiction, raising the paradoxical question of how one mind-altering substance can override dependence on another.
Vice: Microdosing Psilocybin to Treat Depression
Vice speaks to a woman who’s been trialling a psilocybin microdose treatment for a month, and the doctor who devised the method.
Fortune: Microdosing in the Workplace
Silicon Valley legends. Billionaire financiers. Patent attorneys. They’re all microdosing, and seeing the benefits.
Wired: Magic Mushrooms to Treat Depression & PTSD
Activists, entrepreneurs, and doctors in the US and Canada are working to on psilocybin psychotherapy and calling for a psychedelic revolution.
Healthline: The Future of Pharmaceuticals
Could Magic Mushrooms Ever Replace Today’s Antidepressants?
Healthline: FDA Puts ‘Magic Mushroom’ Ingredient on Fast Track for Depression Treatment
Clinical trials to determine how effective psilocybin is in treating depression.
The Guardian: How Psychedelic Drugs Treat Depression
Scientists have been comparing psilocybin to conventional antidepressants – and the results are likely to be game-changing.
Futurism: Magic Mushroom Microdosing
A micro dose of magic mushrooms could unleash your creativity and improve your cognitive abilities.
Healthline: A Beginners Guide to Microdosing
Microdosing: ‘Smart’ Psychedelics Explained
Sociedelic: Using Mushrooms Reconstructs the Brain
New research has shown that using “magic mushrooms” might rewire the brain, leading people to have entirely new experiences.
Popular Science: Study: Magic Mushrooms Are the Safest Drug
If you’re looking to play it safe when it comes to illicit substances, look no further than the humble shroom. It’s non-addictive, hard to overdose on, and you can grow it yourself.
US National Library of Medicine National Institutes of Health
Given the prevalence of persistent suffering and growing acceptance of physician-hastened death as a medical response, it is time to revisit the legitimate therapeutic use of psychedelics.
Sage Journals: Powerful substances in tiny amounts: An Interview Study of Psychedelic Microdosing
Evidence of a group of users taking small doses of psychedelics not for the purpose of intoxication but to enhance everyday functioning.
Sage Journals: Psilocybin Produces Substantial and Sustained Decreases in Depression & Anxiety in Patients with Life-threatening Cancer
psilocybin may decrease depression and anxiety in cancer patients. The effects of psilocybin were studied in 51 cancer patients with life-threatening diagnoses and symptoms of depression and/or anxiety.
Sage Journals: Rapid & Sustained Symptom Reduction Following Psilocybin Treatment for Anxiety & Depression in Patients with Life-threatening Cancer
Clinically significant anxiety and depression are common in patients with cancer, and are associated with poor psychiatric and medical outcomes. Historical and recent research suggests a role for psilocybin to treat cancer-related anxiety and depression.
The Lancet: Psilocybin with Psychological Support for Treatment-resistant Depression: An Open-label Feasibility Study
studies have assessed the therapeutic potential of psilocybin for various conditions, including end-of-life anxiety,
obsessive-compulsive disorder, and smoking and alcohol dependence, with promising preliminary results.
Science Daily: Potential of Psilocybin to Alleviate Psychological and Spiritual Distress in Cancer Patients is Revealed
A recently published book chapter reviews the potential of a novel psychoactive drug, psilocybin, in alleviating the psychological and spiritual distress that often accompanies a life-threatening cancer diagnosis.
Therapsil is a coalition of professionals dedicated to providing access to Psilocybin Therapy for Canadians with a palliative diagnosis.
A community of professionals with a multidisciplinary interest in the science, healing, education, and business of psychedelics.
The Multidisciplinary Association for Psychedelic Studies (MAPS) Canada is committed to planning, conducting and publishing scientific research and education supporting the beneficial uses of psychedelic medicines, including treatment for medical conditions, neuroscience, creativity and spirituality.
Working in the areas of health and wellness, community organizing and restorative justice, and teaching and research, Psychedelic psychotherapy is an interdisciplinary cooperative who advocate for the therapeutic, spiritual and cultural use of plant medicines and psychedelic substances for personal and collective healing and transformation.
Spirit Plant Medicine
A conference for the healing and awakening properties of spirit plant medicines. conference to discover and develop multiple uses of entheogenic medicines.
Vote Yes On 109
Measure 109 is a carefully crafted ballot initiative supported by medical experts, veterans, and people from over 300 Oregon cities to bring this “breakthrough therapy” to Oregon.
Psychoactive Mushroom Decriminalization in Denver Colorado, 2019.